Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition,
With pharmaceutical spending at record levels, employers are looking for solutions and are hopeful that biosimilars can play a role in controlling costs. On this episode of "Not So Different," Elizabeth Mitchell and Lauren Vela (from EmployersRx founding member Pacific Business Group on Health) spoke with Allison Inserro of The Center for Biosimilars about the
SVEF Joins PBGH, ERIC and National Alliance in Calling on Congress to Alleviate the High Cost of Prescription Drugs for Employers and Families WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) welcomes the Silicon Valley Employers Forum (SVEF) as a member in their fight to reform prescription drug pricing at the federal level. EmployersRx
Elements of Policy Platform—the CREATES Act and “Purple Book” Transparency—Advance Through Congress; Large Issues Remain on Table for 2020 WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) applauded Congress for including the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act and portions of the Biologic Patent Transparency Act in an omnibus government
WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) issued this statement in conjunction with the ongoing debate of the Lower Drug Costs Now Act of 2019 (H.R. 3), the Prescription Drug Pricing Reduction Act (S. 2543), the Lower Health Care Costs Act (S. 1895), and other legislation proposed by both parties in the U.S.
A trio of employer groups has formed a new partnership to advocate for policies that address the problem of high—and growing—drug costs. Read about EmployersRx from The Center for Biosimilars >
When it comes to lowering skyrocketing drug prices, employers are making their voices heard on drug price transparency, drug price increase caps, and other price reducing strategies through the new coalition Employers' Prescription for Affordable Drugs (EmployersRx). Read about EmployersRx on HealthPayerIntelligence >
Employers’ Prescription for Affordable Drugs uniting to advance competition, transparency and value WASHINGTON, D.C., October 09, 2019 – The Pacific Business Group on Health (PBGH), The ERISA Industry Committee (ERIC) and the National Alliance of Healthcare Purchaser Coalitions (National Alliance) have partnered to launch the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition uniting employers